Researchers have discovered a new class of antibodies that could provide novel treatment options for malaria, which remains a major global health issue. With an estimated 263 million cases reported in 2023, the need for new interventions is urgent. The findings, published in Science, indicate that these antibodies target the sporozoite surface of the malaria parasite, potentially paving the way for next-generation antimalarial strategies. Although initial tests showed promise in mice, further clinical trials are necessary before these treatments become widely available. Experts agree that innovative solutions are essential to combat the growing malaria burden.
The discovery of a new target on the sporozoite surface represents a great breakthrough that could help development of a new next-generation antimalarial interventions.
While these vaccines are a big step forward in the fight against malaria, the consensus in the field is that additional tools are still urgently needed to reduce malaria burden.
Collection
[
|
...
]